Collaborative research in myositis-related disorders: MIHRA, a global shared community model
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023728%3A_____%2F24%3AN0000023" target="_blank" >RIV/00023728:_____/24:N0000023 - isvavai.cz</a>
Result on the web
<a href="https://doi.org/10.55563/clinexprheumatol/hc1lsf" target="_blank" >https://doi.org/10.55563/clinexprheumatol/hc1lsf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.55563/clinexprheumatol/hc1lsf" target="_blank" >10.55563/clinexprheumatol/hc1lsf</a>
Alternative languages
Result language
angličtina
Original language name
Collaborative research in myositis-related disorders: MIHRA, a global shared community model
Original language description
Myositis International Health and Research Collaborative Alliance (MIHRA) is a newly formed purpose-built non-profit charitable research organization dedicated to accelerating international clinical trial readiness, global professional and lay education, career development and rare disease advocacy in IIM-related disorders. In its long form, the name expresses the community's scope of engagement and intent. In its abbreviation, MIHRA, conveys linguistic roots across many languages, that reflects the IIM community's spirit with meanings such as kindness, community, goodness, and peace. MIHRA unites the global multi-disciplinary community of adult and pediatric healthcare professionals, researchers, patient advisors and networks focused on conducting research in and providing care for pediatric and adult IIM-related disorders to ultimately find a cure. MIHRA serves as a resourced platform for collaborative efforts in investigator-initiated projects, consensus guidelines for IIM assessment and treatment, and IIM-specific career development through connecting research networks.MIHRA's infrastructure, mission, programming and operations are designed to address challenges unique to rare disease communities and aspires to contribute toward transformative models of rare disease research such as global expansion and inclusivity, utilization of community resources, streamlining ethics and data-sharing policies to facilitate collaborative research. Herein, summarises MIHRA operational cores, missions, vision, programming and provision of community resources to sustain, accelerate and grow global collaborative research in myositis-related disorders.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30226 - Rheumatology
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2024
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Clinical and Experimental Rheumatology
ISSN
0392-856X
e-ISSN
1593-098X
Volume of the periodical
42
Issue of the periodical within the volume
2
Country of publishing house
IT - ITALY
Number of pages
6
Pages from-to
207-212
UT code for WoS article
001343940900001
EID of the result in the Scopus database
2-s2.0-85187957095